	Health Disparities and Ethical Considerations for AI Integration in Mammography. J Health Care Poor Underserved Davis K, Solberg LB. PMID: 42969134 [PubMed - indexed for MEDLINE]
	High Risk Latinas Awareness and Interest in Self-collection for HPV Testing to Prevent Cervical Cancer. J Health Care Poor Underserved Guzman CEV, Martinez C, Layman KA, Rosenkranz SJ. PMID: 42969132 [PubMed - indexed for MEDLINE]
	Mechanistic Study of GSDME and CXCL10 in SUV39H1-Mediated Pyroptosis and Immune Suppression in Cervical Cancer. Cancer Med Zhang L, Sheng P, Cai D, Zhao Z, Wu X, Gao Y. PMID: 42968616 [PubMed - indexed for MEDLINE]
	Cervical cancer awareness among Namibian women: Perspectives of primary healthcare nurses. Afr J Reprod Health Nashandi TN, Downing C. PMID: 42968590 [PubMed - indexed for MEDLINE]
	Effect of Fucoidan on Chemotherapy Efficacy via MAPK Pathway Modulation in Cervical Cancer. J Nutr Sci Vitaminol (Tokyo) Lee JW, Lim SY. PMID: 42968243 [PubMed - indexed for MEDLINE]
	Retrospective Chart Review Indicates Earlier Age of Endometrial Cancer Diagnosis and Elevated Housing and Transportation Vulnerability in Hispanic and Native American Populations. Cancer Med Jimenez NR, Mendoza R, Flores E, Cui H, , Chase DM, Roe DJ, Herbst-Kralovetz MM. PMID: 42968191 [PubMed - indexed for MEDLINE]
	Which combinations of behaviour change techniques work best? Evidence from meta-review of interventions addressing healthy diet and exercise after breast cancer. Int J Behav Nutr Phys Act Boberska M, Wietrzykowska D, Kulis E, Kuzminska J, Zalewska-Lunkiewicz K, Karaglani E, Mourouti N, Manios Y, Luszczynska A, MELIORA Consortium. PMID: 42968164 [PubMed - indexed for MEDLINE]
	Safety and treatment duration of ribociclibâ€‰+â€‰nonsteroidal aromatase inhibitor in HR+/HER2- early breast cancer: a phase 3 randomized controlled trial (NATALEE). Breast Cancer Res Rugo HS, Harbeck N, Hortobagyi GN, O'Shaughnessy J, Huang CS, Martin M, Juric D, Pistilli B, Xu B, De Laurentiis M, Untch M, Afenjar K, Gao M, Li Z, Bolotova N, Waters S, Barrios C. PMID: 42968162 [PubMed - indexed for MEDLINE]
	Utilization and outcome estimates of cervical precancer screening and associated factors among female health workers in Ghana: implications for primary screening programs. BMC Health Serv Res Effah K, Tekpor E, Wormenor CM, Klutsey GB, Sesenu E, Tsinigo EY, Kemawor S, Danyo S, Atuguba BH, Legbedze GG, Essel NOM, Donkoh ET. PMID: 42968109 [PubMed - indexed for MEDLINE]
	Implementing physical activity counselling versus structured exercise for breast cancer survivors in the PAC-WOMAN trial: mapping TICD-based determinants to the behaviour change wheel. BMC Health Serv Res Franco S, Carraça EV, Nobre I, Rodrigues B, Silva CS, Silva MN. PMID: 42968066 [PubMed - indexed for MEDLINE]
	Fallopian tube cytology combined with p53 and PAX-8 immunocytochemistry in diagnosing ovarian carcinoma: a prospective study. BMC Cancer Lekka S, Psomiadou V, Panoskaltsis T, Tsouma E, Tzaida O, Trihia H, Pouliakis A, Korfias D, Giannakas P, Vakas P, Vlahos N, Vorgias G. PMID: 42968063 [PubMed - indexed for MEDLINE]
	Breast reconstruction and breast cancer surgery in Brazil's public health system: a nationwide interrupted time-series analysis, 2008-2024. BMC Womens Health Piccin Padilla M, Siqueira MM, Delpino FM, de Freitas JBJ, Podgaec S, de Andrade FEM. PMID: 42968050 [PubMed - indexed for MEDLINE]
	miR-206 orchestrates breast cancer radiosensitivity through a SIRT1/p53 feedback loop: a network medicine modelling study. BMC Bioinformatics Fontinele DO, Reiniger KAR, Azevedo AHD, Lima JPMS, Gupta S. PMID: 42968013 [PubMed - indexed for MEDLINE]
	Neoadjuvant concurrent or sequential anthracycline-containing chemotherapy and HER2-targeted agents for HER2-positive breast cancer: a randomized phase 2 study (METIS). Signal Transduct Target Ther Zheng Q, Wang S, Wu Z, Zhong M, Xu F, Ma S, Zhang Y, Zhang L, Shi Y, Wang Y, Huang H, Ma X, Xu X, Li H, Li J, Bi X, Huang J, Jiang K, An X, Hong R, Chen M, Xue C, Zhong Y, Yuan Z, Xia W. PMID: 42967914 [PubMed - indexed for MEDLINE]
	From staging to changing strategy: [(18)F]FDG PET/MRI's impact on treatment planning in early breast cancer. Eur J Cancer Di Micco R, Corona SP, Bagnardi V, Riccardi S, Canevari C, Gallivanone F, Antunovic L, Scifo P, Neri I, Gelardi F, Magnani P, Losio C, Venturini E, Della Vecchia G, Ferrarese G, Rotmensz N, Zuber V, Baleri S, Cisternino G, Calabretto F, Rampa M, Pitoni L, Viale G, Licata L, Sassi I, Bianchini G, Panizza P, Chiti A, Gentilini OD. PMID: 42967455 [PubMed - as supplied by publisher]
	Is fear of recurrence a determinant of breast self-examination awareness in women who have survived breast cancer? Support Care Cancer Y, Balc, Arslan S, Kany. PMID: 42967242 [PubMed - indexed for MEDLINE]
	Decision regret following rapid genetic testing at the time of breast cancer diagnosis. Cancer Hsu LF, Eisen A, Poll A, Lim DW, Wright FC, Hanrahan R, Hosein A, Pal T, Narod S, Metcalfe K. PMID: 42967224 [PubMed - indexed for MEDLINE]
	Unraveling the EMT Spectrum in Aggressive Breast Cancer: Bridging Molecular Hybrid States with Functional Assay Interpretation. Onco Targets Ther Utami N, Alhaq KF, Oktavia N, Bashari MH, Usman HA, Khairani AF. PMID: 42967165 [PubMed]
	Racial Perceptions of Communication in Breast Cancer Diagnosis. J Racial Ethn Health Disparities Hora JA, Almeida MA, Souza ES, Vale DB. PMID: 42966829 [PubMed - as supplied by publisher]
	Integrating Immunogenetics, Single-Cell Transcriptomics, and AI-Assisted Drug Discovery Reveals CXCL10-Associated Immune Remodelling in Breast Cancer. Int J Immunogenet Wang H, Li Y, Chen Y, Chen H, He Y, Zhou Y. PMID: 42965880 [PubMed - as supplied by publisher]

Articles 1 - 20 / 337439

Page 1 of 16872



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy